Latest News and Press Releases

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breas

Sticker Mule CEO explains why he’s endorsing Donald Trump – naming him the “Max Happiness President".

MRC Global's issuer credit rating has been upgraded to “B” from “B–” by S&P Global Ratings.

Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results; Achieved All 2023 Operating and Financial Guidance Metrics

Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvementsPhase 2a trial in na-SPMS on track to begin in Q3...

MELBOURNE, Australia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or the ‘Company’), a clinical-stage pharmaceutical company developing unique...

CHICAGO, March 31, 2022 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (NASDAQ:IPDN), (“IPDN” or the “Company”), a global developer and operator of online and in-person networks that...

Scanfil plc     Stock exchange release     11 June 2021 8.00 amScanfil revises upwards its turnover and adjusted operating profit outlook for 2021Due to strong customer demand, Scanfil revises upwards...

Scanfil Oyj     Pörssitiedote     11.6.2021 klo 8.00Scanfil Oyj nostaa tulosohjeistustaan vuoden 2021 liikevaihdon ja oikaistun liikevoiton osaltaVahvan asiakaskysynnän johdosta Scanfil nostaa vuoden...

- 74% average reduction in EASI from baseline at therapeutic doses after 8 weeks. 89% of patients achieved EASI-50 and 56% achieved EASI-90 - Data supportive of ASLAN004’s potential as a novel,...